Average Co-Inventor Count = 6.20
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Celgene Avilomics Research, Inc. (18 from 44 patents)
2. Celgene Car LLC (13 from 44 patents)
3. The Brigham and Women's Hospital, Inc. (6 from 1,370 patents)
4. Massachusetts Eye and Ear Infirmary (5 from 262 patents)
5. Avila Therapeutics, Inc. (2 from 5 patents)
6. Duke University (1 from 2,007 patents)
7. Biochemics, Inc. (1 from 12 patents)
40 patents:
1. 11542492 - Ligand-directed covalent modification of protein
2. 11351168 - 2,4-disubstituted pyrimidines useful as kinase inhibitors
3. 11160808 - Compounds that enhance Atoh1 expression
4. 11098061 - MK2 inhibitors and uses thereof
5. 10828300 - Substituted 2,4-diaminopyrimidines as kinase inhibitors
6. 10662195 - Protein kinase conjugates and inhibitors
7. 10596172 - 2,4-disubstituted pyrimidines useful as kinase inhibitors
8. 10406163 - Compounds that enhance Atoh1 expression
9. 10138256 - MK2 inhibitors and uses thereof
10. 10010548 - 2,4-disubstituted pyrimidines useful as kinase inhibitors
11. 9987276 - Substituted 2,4-diaminopyrimidines as kinase inhibitors
12. 9980964 - ERK inhibitors and uses thereof
13. 9796700 - ERK inhibitors and uses thereof
14. 9694086 - HCV protease inhibitors and uses thereof
15. 9676785 - HCV protease inhibitors and uses thereof